|
Resveratrol mitigates diabetes-induced cardiac dysfunction via SIRT1/PPAR-α/PGC-1 pathway.
Mol Genet Genomics
Fu R, Hao J.
PMID: 41348235 [PubMed - indexed for MEDLINE]
|
|
Cost-effectiveness of a single-layer high compression bandage versus Unna's boot for venous leg ulcer treatment: the VENOS trial.
J Wound Care
Fuhrmann AC, Cordova FP, Machado DO, Mocellin D, Johnson JA, Paskulin LMG.
PMID: 41348198 [PubMed - indexed for MEDLINE]
|
|
Application of telemedicine in home healthcare for patients with diabetic foot ulcers: a randomised controlled study.
J Wound Care
Hai-Ping Y, Hui-Ren Z, Ying-Jie G, Xiao-Jing L, Hung YY, Jia-Li Y, Yi-Li G.
PMID: 41348195 [PubMed - indexed for MEDLINE]
|
|
Arterial wall enhancement on high-resolution vessel-wall MRI correlates with stenosis burden and large-artery atherosclerosis subtype in ischemic stroke.
Neurosurg Rev
Zheng Q, Gong T.
PMID: 41348180 [PubMed - indexed for MEDLINE]
|
|
CAR T-cell therapy and bispecific antibodies in the management of multiple myeloma.
Hematology Am Soc Hematol Educ Program
Dima D, Banerjee R, Hansen DK.
PMID: 41348052 [PubMed - indexed for MEDLINE]
|
|
Anticoagulants in hematologic malignancies: what is the data?
Hematology Am Soc Hematol Educ Program
Alyamany R, Houghton DE.
PMID: 41348050 [PubMed - indexed for MEDLINE]
|
|
Can I stop my treatment, doctor? Is MRD-guided therapy ready for prime time?
Hematology Am Soc Hematol Educ Program
Derman BA.
PMID: 41348032 [PubMed - indexed for MEDLINE]
|
|
How to approach the high-risk myeloma from induction through relapse?
Hematology Am Soc Hematol Educ Program
Weisel KC, Schaefers C, Leypoldt LB.
PMID: 41348031 [PubMed - indexed for MEDLINE]
|
|
Transplant in myeloma: what is its role?
Hematology Am Soc Hematol Educ Program
Rodriguez C.
PMID: 41348025 [PubMed - indexed for MEDLINE]
|
|
What is the best induction for myeloma for the fit patient?
Hematology Am Soc Hematol Educ Program
Shah NN, Kaufman JL.
PMID: 41348024 [PubMed - indexed for MEDLINE]
|
|
Choosing the optimal maintenance strategy in multiple myeloma.
Hematology Am Soc Hematol Educ Program
Puliafito B, Cirstea D, Raje N.
PMID: 41348019 [PubMed - indexed for MEDLINE]
|
|
Implementation failure: thromboprophylaxis in ambulatory patients with cancer.
Hematology Am Soc Hematol Educ Program
Butera E, Wang TF, Pola R, Carrier M.
PMID: 41348016 [PubMed - indexed for MEDLINE]
|
|
Managing patients with a history of arterial disease and new venous thromboembolism.
Hematology Am Soc Hematol Educ Program
Deng E, Passam FH.
PMID: 41348011 [PubMed - indexed for MEDLINE]
|
|
Updates in antithrombotic therapy in coronary and peripheral artery disease.
Hematology Am Soc Hematol Educ Program
Pollak AW.
PMID: 41348008 [PubMed - indexed for MEDLINE]
|
|
When sickle cell trait is not just trait: risk of VTE.
Hematology Am Soc Hematol Educ Program
Naik RP, Pawlinski R, Key NS.
PMID: 41348002 [PubMed - indexed for MEDLINE]
|
|
Sickle cell disease: managing thromboembolism.
Hematology Am Soc Hematol Educ Program
Babu K, Wun T.
PMID: 41347992 [PubMed - indexed for MEDLINE]
|
|
Endless possibilities and how to exploit them? What is the optimal treatment sequence?
Hematology Am Soc Hematol Educ Program
Chakraborty R, Bhutani D, Lentzsch S.
PMID: 41347981 [PubMed - indexed for MEDLINE]
|
|
Cryptogenic stroke: definitions and management.
Hematology Am Soc Hematol Educ Program
Powers WJ.
PMID: 41347980 [PubMed - indexed for MEDLINE]
|
|
Anticoagulation in malignancy: the patient who bleeds and clots simultaneously.
Hematology Am Soc Hematol Educ Program
Kapoor S, Peseski AM, Ortel TL.
PMID: 41347979 [PubMed - indexed for MEDLINE]
|
|
What's new in hereditary hemorrhagic telangiectasia?
Hematology Am Soc Hematol Educ Program
Kasthuri RS.
PMID: 41347972 [PubMed - indexed for MEDLINE]
|
| |
|
 |
|
